Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy.
about
Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytesSelf-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable anginaMolecular and cellular mechanisms of cardiotoxicity.Extracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2)Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitroERK1/2 antagonizes glycogen synthase kinase-3beta-induced apoptosis in cortical neuronsAkt-mediated cardiomyocyte survival pathways are compromised by G alpha q-induced phosphoinositide 4,5-bisphosphate depletionInvolvement of GADD153 and cardiac ankyrin repeat protein in hypoxia-induced apoptosis of H9c2 cellsRepression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophyGrowth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heartInvolvement of GADD153 and cardiac ankyrin repeat protein in cardiac ischemia-reperfusion injuryMixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transforming growth factor-beta-induced apoptosis in hepatoma cellsAblation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathyRole of cytokine signaling during nervous system developmentGlucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes.Leptin protects cardiomyocytes from serum-deprivation-induced apoptosis by increasing anti-oxidant defence.Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophyCardiotrophin-1 (CT-1): a novel hypertrophic and cardioprotective agent.Cell death, non-invasively assessed by intrinsic fluorescence intensity of NADH, is a predictive indicator of functional differentiation of embryonic stem cells.Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3.Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism.An essential role of the JAK-STAT pathway in ischemic preconditioning.Evolution and pathophysiology of chronic systolic heart failure.Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins.Apoptosis in the ischemic reperfused myocardium.Expression and effects of cardiotrophin-1 (CT-1) in human airway smooth muscle cellsThe lack of cardiotrophin-1 alters expression of interleukin-6 and leukemia inhibitory factor mRNA but does not impair cardiac injury response.A synopsis of research in cardiac apoptosis and its application to congestive heart failureMitogen-activated protein kinase kinase antagonized fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression.Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age.Voluntary exercise-induced changes in beta2-adrenoceptor signalling in rat ventricular myocytesAging and the cardiac collagen matrix: Novel mediators of fibrotic remodellingNuclear and mitochondrial signalling Akts in cardiomyocytesEffects of thapsigargin and phenylephrine on calcineurin and protein kinase C signaling functions in cardiac myocytes.Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue.Mesencephalic astrocyte-derived neurotrophic factor is an ischemia-inducible secreted endoplasmic reticulum stress response protein in the heart.Cardioprotective growth factors.JAK redux: a second look at the regulation and role of JAKs in the heart.Stem cell death and survival in heart regeneration and repair.
P2860
Q24308695-0217D73E-B984-460E-8302-054110F9A9A0Q24600230-34C71C05-73A4-472F-A815-D344E57720EBQ24683609-34CF6DA8-193B-4895-B318-4E542E1D2E87Q24814079-AB90E02B-7480-46DB-B25F-251465EE1E38Q28205358-D2807D41-C6A2-4204-A3A7-BCF2A01B2819Q28344062-2AD67DB6-C8A9-4A39-9C17-08080D0EC03FQ28568735-0E7C600D-89D1-4FB9-9919-2773B950CDCAQ28571127-AF02E3D6-A571-4AED-B26E-0F55EB033B76Q28571406-A2BCDCED-C71B-4032-8C27-D3E2150B6469Q28571438-5AE098B1-FC11-4FF8-8928-CA57211B7320Q28576178-2BE58649-3A2E-460B-A82E-C2347EF4D32BQ28576800-F40D78AB-0DA5-40EF-9398-C853F36F04E2Q28578617-7917F070-00B7-451A-8AFC-822444D7B665Q28587879-3A0085A6-6B64-45CB-826B-FB9794F4490DQ30450870-3CBBDF7B-4342-474E-AFC1-7E5D3318D783Q33178140-40B0D5D9-5199-44A0-81BD-B5E0E166706AQ33608137-44E9B614-60FF-4C5F-A516-CE614F294187Q33774336-BEBE9E17-FA49-44CD-9C04-A51E6CAFE5D4Q33785805-44D1C8F1-BD87-4E8A-BAAE-39D905813662Q33893798-F420D962-1AD3-41C2-8C39-17C896433C4BQ33897327-204D9673-B1DF-4C27-B1D8-502729704A5CQ33902374-09F6AB00-4F32-46E0-B8EB-B05CFE2CFE22Q33929635-8D8CE1CC-164B-4CC7-A45D-C9B0353CCF46Q34088198-AA0BB963-DBE9-48E7-89EE-A298D0D2B083Q34403963-E2BBA309-D703-475D-947C-47DB4FE62531Q34473433-1023D61E-C34E-4281-97E7-D6FCB66D9A5FQ35045947-FC3D7228-7E1D-425E-98B6-0AE2AD7A83BAQ35633386-93462CCC-388D-4F4B-ADB9-ED12EAEB504BQ36015485-40941FB0-50AD-4F9D-AAE7-BB92E1A663EAQ36401247-FC605F69-526A-4FD5-ABD8-2F795DD3A0BAQ36689956-8CE72D9C-5C06-4848-B757-D2CBEA43B60EQ37035415-D4A662D0-E7B0-4276-A687-A694911EB256Q37096257-AF6132DD-0A3A-46AC-9415-3740132C32CAQ37176193-CAD0A248-C1BD-4FC3-BF0C-CB0286433FA0Q37190351-A56499D2-5AE2-4B3A-AF8D-15FFD905B923Q37319985-84A991EF-E4BA-476F-8835-DAB9076E3184Q37353324-DECDC96D-A6AF-4B92-B540-017D46FB238FQ37393585-53A1D14E-7BB5-4BCA-ACDA-351F798B5209Q37430884-3877D8AF-BBEB-42A3-B962-87CA0AC33140Q37545373-66F95348-9AE3-4CE1-B488-996536E9A42C
P2860
Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Cardiotrophin 1 (CT-1) inhibit ...... r myocardial cell hypertrophy.
@en
Cardiotrophin 1
@nl
type
label
Cardiotrophin 1 (CT-1) inhibit ...... r myocardial cell hypertrophy.
@en
Cardiotrophin 1
@nl
prefLabel
Cardiotrophin 1 (CT-1) inhibit ...... r myocardial cell hypertrophy.
@en
Cardiotrophin 1
@nl
P2093
P2860
P356
P1476
Cardiotrophin 1 (CT-1) inhibit ...... r myocardial cell hypertrophy.
@en
P2093
P2860
P304
P356
10.1074/JBC.272.9.5783
P407
P577
1997-02-01T00:00:00Z